SCHEMBL7069966

SCHEMBL7069966

CC(C)(C)C(=O)CN1C(=O)CN=C(c2ccccc2Cl)c2cc(Cl)ccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 7/20 0.64
LMNA P02545 1/20 0.62
MAPT P10636 5/20 0.62
MEN1 O00255 1/20 0.62
USP2 O75604 1/20 0.62
KMT2A Q03164 1/20 0.62
CYP1A2 P05177 1/20 0.56
NPSR1 Q6W5P4 2/20 0.55
ALDH1A1 P00352 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MCL1 Q07820 1/20 0.53
OPRK1 P41145 3/20 0.53
NR1I2 O75469 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
OPRM1 P35372 1/20 0.53
HTR1A P08908 1/20 0.52
DRD3 P35462 1/20 0.52
HTR3A P46098 1/20 0.52
KCNH2 Q12809 1/20 0.52
GHSR Q92847 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6940247 0.89 NPSR1 (0.68) TP53LMNAMAPTCYP1A2NPSR1
SCHEMBL11802020 0.86 MAPT (0.65) TP53LMNAMAPTMEN1USP2
SCHEMBL11769344 0.84 TP53 (0.72) TP53LMNAMAPTMEN1USP2
SCHEMBL11783865 0.81 TP53 (0.66) TP53LMNAMAPTMEN1USP2
SCHEMBL27405126 0.81 TP53 (0.69) TP53LMNAMAPTMEN1USP2
SCHEMBL11579807 0.80 TP53 (0.67) TP53LMNAMAPTMEN1USP2
SCHEMBL11789031 0.80 TP53 (0.62) TP53LMNAMAPTMEN1USP2
SCHEMBL8301353 0.80 TP53 (0.56) TP53LMNAMAPTMEN1USP2
SCHEMBL11578043 0.79 TP53 (0.66) TP53LMNAMAPTMEN1USP2
SCHEMBL11578274 0.79 TP53 (0.66) TP53LMNAMAPTMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1342719-A1 Benzodiazepine derivatives useful as CCK-Receptor Antagonists YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2003-09-10 EP disclosed